Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative Methods.
Journal
Medical care
ISSN: 1537-1948
Titre abrégé: Med Care
Pays: United States
ID NLM: 0230027
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
19
3
2020
medline:
6
5
2020
entrez:
19
3
2020
Statut:
ppublish
Résumé
The Department of Veterans Affairs (VA) cares for more patients with hepatitis C virus (HCV) than any other US health care system. We tracked the implementation strategies that VA sites used to implement highly effective new treatments for HCV with the aim of uncovering how combinations of implementation strategies influenced the uptake of the HCV treatment innovation. We applied Configurational Comparative Methods (CCMs) to uncover causal dependencies and identify difference-making strategy configurations, and to distinguish higher from lower HCV treating sites. We surveyed providers to assess VA sites' use of 73 implementation strategies to promote HCV treatment in the fiscal year 2015. CCMs were used to identify strategy configurations that uniquely distinguished higher HCV from lower HCV treating sites. From the 73 possible implementation strategies, CCMs identified 5 distinct strategy configurations, or "solution paths." These were comprised of 10 individual strategies that collectively explained 80% of the sites with higher HCV treatment starts with 100% consistency. Using any one of the following 5 solution paths was sufficient to produce higher treatment starts: (1) technical assistance; (2) engaging in a learning collaborative AND designating leaders; (3) site visits AND outreach to patients to promote uptake and adherence; (4) developing resource sharing agreements AND an implementation blueprint; OR (5) creating new clinical teams AND sharing quality improvement knowledge with other sites AND engaging patients. There was equifinality in that the presence of any one of the 5 solution paths was sufficient for higher treatment starts. Five strategy configurations distinguished higher HCV from lower HCV treating sites with 100% consistency. CCMs represent a methodological advancement that can help inform high-yield implementation strategy selection and increase the efficiency and effectiveness of future implementation efforts.
Sections du résumé
BACKGROUND
The Department of Veterans Affairs (VA) cares for more patients with hepatitis C virus (HCV) than any other US health care system. We tracked the implementation strategies that VA sites used to implement highly effective new treatments for HCV with the aim of uncovering how combinations of implementation strategies influenced the uptake of the HCV treatment innovation. We applied Configurational Comparative Methods (CCMs) to uncover causal dependencies and identify difference-making strategy configurations, and to distinguish higher from lower HCV treating sites.
METHODS
We surveyed providers to assess VA sites' use of 73 implementation strategies to promote HCV treatment in the fiscal year 2015. CCMs were used to identify strategy configurations that uniquely distinguished higher HCV from lower HCV treating sites.
RESULTS
From the 73 possible implementation strategies, CCMs identified 5 distinct strategy configurations, or "solution paths." These were comprised of 10 individual strategies that collectively explained 80% of the sites with higher HCV treatment starts with 100% consistency. Using any one of the following 5 solution paths was sufficient to produce higher treatment starts: (1) technical assistance; (2) engaging in a learning collaborative AND designating leaders; (3) site visits AND outreach to patients to promote uptake and adherence; (4) developing resource sharing agreements AND an implementation blueprint; OR (5) creating new clinical teams AND sharing quality improvement knowledge with other sites AND engaging patients. There was equifinality in that the presence of any one of the 5 solution paths was sufficient for higher treatment starts.
CONCLUSIONS
Five strategy configurations distinguished higher HCV from lower HCV treating sites with 100% consistency. CCMs represent a methodological advancement that can help inform high-yield implementation strategy selection and increase the efficiency and effectiveness of future implementation efforts.
Identifiants
pubmed: 32187105
doi: 10.1097/MLR.0000000000001319
pmc: PMC7161717
mid: NIHMS1564850
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e31-e38Subventions
Organisme : Intramural VA
ID : VA999999
Pays : United States
Références
Health Econ Rev. 2016 Dec;6(1):23
pubmed: 27271178
Fed Pract. 2018 Jul;35(7):24-29
pubmed: 30766371
Hepatology. 2016 Aug;64(2):405-14
pubmed: 27115523
Implement Sci. 2015 Aug 07;10:109
pubmed: 26249843
J Clin Sleep Med. 2019 Jan 15;15(1):89-99
pubmed: 30621833
J Child Psychol Psychiatry. 2019 Apr;60(4):430-450
pubmed: 30144077
J Mix Methods Res. 2016 Jul;10(3):251-272
pubmed: 27429602
Infect Dis Clin North Am. 2018 Jun;32(2):281-292
pubmed: 29778256
Annu Rev Public Health. 2019 Apr 1;40:423-442
pubmed: 30633710
Implement Sci. 2014 Mar 26;9:39
pubmed: 24669765
Ann Intern Med. 2017 Oct 3;167(7):499-504
pubmed: 28973196
Implement Sci. 2017 May 11;12(1):60
pubmed: 28494811
Implement Sci. 2019 Jan 14;14(1):3
pubmed: 30642342
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Cochrane Database Syst Rev. 2019 Jan 28;1:CD011651
pubmed: 30687940
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Natl Cancer Inst Monogr. 2012 May;2012(44):34-41
pubmed: 22623594